ReviewSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2025
[Clinical Practice and Quality Control Strategies for Complex Minimally Invasive Pancreatic Surgery].
Review in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With continuous advancements in the concepts of minimally invasive surgery, pancreatic surgery is gradually undergoing a transformative shift toward minimally invasive approaches. Compared with traditional open surgeries, minimally invasive procedures offer advantages such as reduced trauma, faster recovery, and fewer complications. However, due to the complex anatomical structure of the pancreas and the technical difficulties of surgical procedures, the widespread adoption of minimally invasive pancreatic surgery still faces numerous technical challenges. Currently, laparoscopic pancreaticoduodenectomy (LPD) is primarily performed in large, specialized centers with experienced teams and well-established systems. Given the high technical complexity and associated risks, reducing intraoperative risks and minimizing postoperative complications remain key focuses and major challenges in current research. This review is focused on intraoperative risk control and postoperative complication management in complex minimally invasive pancreatic surgery. We conducted a comprehensive review of recent advances in China and abroad, covering the latest progress in preoperative assessment, intraoperative procedures, complication prevention, quality management, and technological innovation. Furthermore, we discussed potential development directions in minimally invasive pancreatic surgery, including technical refinement, discipline development, procedural standardization, and multi-center collaboration. Our goal is to promote a continued progress toward more standardized, personalized, and intelligent surgical practices-ultimately benefiting a broader population of patients with pancreatic diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.